Patents matching “malignant”

US 11980607

Methods of treating malignant lymphoproliferative disorders

ACTUATE THERAPEUTICS INC. · Granted May 14, 2024 · Expires May 9, 2044

US 11885806

Method for depleting malignant T-cells

AUTOLUS LIMITED · Granted Jan 30, 2024 · Expires Jan 25, 2044

US 11885807

Method for depleting malignant T-cells

AUTOLUS LIMITED · Granted Jan 30, 2024 · Expires Jan 25, 2044

US 11510904

Methods of treating malignant lymphoproliferative disorders

ACTUATE THERAPEUTICS INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

US 11385233

Methods of depleting malignant T-cells

AUTOLUS LIMITED · Granted Jul 12, 2022 · Expires Jul 7, 2042

US 10568901

Micro-RNA for the treatment of malignant solid tumors and metastasis

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 25, 2020 · Expires Feb 20, 2040

US 10172937

Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies

Five Prime Therapeutics, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

US 9808505

Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)

The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

US 9242000

Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them

The Regents of the University of California · Granted Jan 26, 2016 · Expires Jan 21, 2036

US 8951971

Lymphatic zip codes in tumors and pre-malignant lesions

The Regents of the University of California · Granted Feb 10, 2015 · Expires Feb 5, 2035

US 8598316

Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

The Regents of the University of California · Granted Dec 3, 2013 · Expires Nov 28, 2033

US 8536132

Lymphatic zip codes in tumors and pre-malignant lesions

The Regents of the University of California · Granted Sep 17, 2013 · Expires Sep 12, 2033

US 7919466

Lymphatic zip codes in tumors and pre-malignant lesions

The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

US 7855191

Agent having a destructive effect on malignant tumors and method for the production thereof

C.Y.L. Pharmazeutika GmbH · Granted Dec 21, 2010 · Expires Dec 16, 2030

US 7723474

Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

US 7598341

Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs

The Regents of the University of California · Granted Oct 6, 2009 · Expires Oct 1, 2029

US 7354582

Use of VEGF antagonists for the treatment of malignant gliomas

REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

US 7118752

Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I

UNIVERSITY OF CONNECTICUT · Granted Oct 10, 2006 · Expires Oct 5, 2026

US 6720344

Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants

The Board of Regents of the University of Texas System · Granted Apr 13, 2004 · Expires Apr 8, 2024

US 6426076

Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy

PASCO Pharmazeutische Präparate GmbH · Granted Jul 30, 2002 · Expires Jul 25, 2022

US 6299873

Method for improvement of radiation therapy of malignant tumors

UNIVERSITY OF CONNECTICUT · Granted Oct 9, 2001 · Expires Oct 4, 2021

US 6214571

Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells

The Regents of the University of California · Granted Apr 10, 2001 · Expires Apr 5, 2021